Elsevier

The Lancet

Volume 334, Issue 8665, 23 September 1989, Pages 709-712
The Lancet

PASSIVE IMMUNISATION OF CHILDREN WITH BOVINE COLOSTRUM CONTAINING ANTIBODIES TO HUMAN ROTAVIRUS

https://doi.org/10.1016/S0140-6736(89)90771-XGet rights and content

Abstract

The efficacy of a 10-day course of bovine colostrum with high antibody titre against the four known human rotavirus serotypes in protecting children against rotavirus infection was examined in patients admitted to hospital. Children aged 3 to 15 months were blocked in pairs according to ward accommodation (ie, isolation or open area). Each block contained 1 treated and 1 control child. The allocation to treatment or control (an artificial infant formula) was randomised. 9 of 65 control children but none of 55 treated children acquired rotavirus infection during the treatment period (p<0·001). The importance of protecting against rotavirus infection was highlighted by the fact that parents of symptomatic rotavirus-positive children sought medical attention seven times more often than did parents of symptomatic rotavirusnegative children (p <0·05).

References (23)

  • Ca Mebus et al.

    Immunity to neonatal calf diarrhea virus

    J Am Vet Med Assoc

    (1973)
  • Cited by (155)

    • Evaluating the effectiveness of colostrum as a therapy for diarrhea in preweaned calves

      2022, Journal of Dairy Science
      Citation Excerpt :

      Bovine colostrum has been evaluated as a therapeutic for diarrhea in several studies across many different species. It has been determined that the severity and duration of acute diarrhea in children can be reduced with colostrum therapy (Davidson et al., 1989; Rathe et al., 2014; Barakat et al., 2020). Similarly, bovine colostrum has been found to reduce diarrhea incidence and the growth of diarrhea causing pathogens in piglets (Sugiharto et al., 2015).

    • Fermented, ultrasonicated, and dehydrated bovine colostrum: Changes in antimicrobial properties and immunoglobulin content

      2020, Journal of Dairy Science
      Citation Excerpt :

      It is known that the immunoglobulins found in BC bind to many human pathogens and allergens and can neutralize infection of human cells, as well as treat gastrointestinal inflammation (Ulfman et al., 2018). Also, passive oral administration of BC has been experimentally evaluated as a preventive or therapeutic modality for a variety of enteric infections (Tacket et al., 1988; Davidson et al., 1989; Tacket et al., 1992; Greenberg and Cello, 1996; Freedman et al., 1998; Savarino et al., 2017). Food formulations with BC can compensate or have a beneficial effect on health due to the addition of specific components if those components are lacking in the daily diet (Santini and Novellino, 2018).

    • Engineering of milk-based beverages: Current status, developments, and consumer trends

      2019, Milk-Based Beverages: Volume 9: The Science of Beverages
    • Isolation of biofunctional bovine immunoglobulin G from milk- and colostral whey with mixed-mode chromatography at lab and pilot scale

      2018, Journal of Chromatography A
      Citation Excerpt :

      Isolated IgG may be used to specifically target pathogenic bacteria in bacterial skin infections without affecting the healthy microflora and causing the development of therapy resistance. The specific titer of immunoglobulins in colostrum against a certain pathogen such as Staphylococcus aureus can be increased by immunizing the cow as described for other pathogens such as enterotoxigenic Escherichia coli [6,7], Clostridium difficile [8,9], Shigella flexneri [10] or rotavirus [11]. Prerequisite of a development of IgG isolated from colostrum as drug substance for therapeutic use, is the standardized production of pure and active IgG at an industrial scale.

    • Passive Immunization

      2017, Plotkin's Vaccines
    View all citing articles on Scopus
    View full text